The BioTech Pharma Summit: Liquid Biopsy 2020 focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers. There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state-of-the-field.
Dit zal plaatsvinden in Lissabon. Meer informatie kunt u vinden op de website.
Meer informatie over de nieuwe richtlijn Preconceptie Dragerschapsonderzoek Hoogrisicogroepen is te vinden op https://t.co/STFRas97us https://t.co/GvZLoY9moD
RT @LudeFranke: Within Lifelines, a prospective population-based study of 167,000 Dutch people, we conduct COVID19 research with the aim to…